Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Sacks

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Medicine|December 4, 2023
Measuring the impact of monoclonal antibody therapiesKa Keat Lim, Kenrick Ng, Sathiyaa Balachandran, et al.
Scientific Reports|November 25, 2017
Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injuryEhsan Sharif-Paghaleh, May Lin Yap, Sarah-Lena Puhl, et al.
Scientific Reports|March 15, 2018
Author Correction: Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injuryEhsan Sharif-Paghaleh, May Lin Yap, Sarah-Lena Puhl, et al.
BMJ Open|March 6, 2025
Multicentre, multi-arm, double-blind randomised placebo-controlled dose-finding trial investigating the safety and Efficacy of MirococePt (APT070) In Reducing delayed graft function In the Kidney ALlograft (EMPIRIKAL-2): study protocol for a randomised controlled trialTheodoros Kassimatis, Alima Rahman, Fayyad Jaradat, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 12, 2017
Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and/or C2Sadam Yaseen, Gregory Demopulos, Thomas Dudler, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2011
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injuryWilhelm J Schwaeble, Nicholas J Lynch, James E Clark, et al.
Ebiomedicine|March 6, 2019
Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samplesSofia Christakoudi, Manohursingh Runglall, Paula Mobillo, et al.
Kidney International|November 2, 2020
Complement activation is a crucial driver of acute kidney injury in rhabdomyolysisIdris Boudhabhay, Victoria Poillerat, Anne Grunenwald, et al.
Diagnostic and Prognostic Research|May 17, 2019
Erratum to: Methods for evaluating medical tests and biomarkersGowri Gopalakrishna, Miranda Langendam, Rob Scholten, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Medicine|December 4, 2023
Measuring the impact of monoclonal antibody therapiesKa Keat Lim, Kenrick Ng, Sathiyaa Balachandran, et al.
Scientific Reports|November 25, 2017
Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injuryEhsan Sharif-Paghaleh, May Lin Yap, Sarah-Lena Puhl, et al.
Scientific Reports|March 15, 2018
Author Correction: Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injuryEhsan Sharif-Paghaleh, May Lin Yap, Sarah-Lena Puhl, et al.
BMJ Open|March 6, 2025
Multicentre, multi-arm, double-blind randomised placebo-controlled dose-finding trial investigating the safety and Efficacy of MirococePt (APT070) In Reducing delayed graft function In the Kidney ALlograft (EMPIRIKAL-2): study protocol for a randomised controlled trialTheodoros Kassimatis, Alima Rahman, Fayyad Jaradat, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 12, 2017
Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and/or C2Sadam Yaseen, Gregory Demopulos, Thomas Dudler, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2011
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injuryWilhelm J Schwaeble, Nicholas J Lynch, James E Clark, et al.
Ebiomedicine|March 6, 2019
Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal samplesSofia Christakoudi, Manohursingh Runglall, Paula Mobillo, et al.
Kidney International|November 2, 2020
Complement activation is a crucial driver of acute kidney injury in rhabdomyolysisIdris Boudhabhay, Victoria Poillerat, Anne Grunenwald, et al.
Diagnostic and Prognostic Research|May 17, 2019
Erratum to: Methods for evaluating medical tests and biomarkersGowri Gopalakrishna, Miranda Langendam, Rob Scholten, et al.
Pageof 3